Hollister Continence Care is committed to making life more rewarding and dignified for the people who use our products and services. We seek to work closely with nurse and patient groups to develop products that improve individual’s dignity and independence. Recognised not only for technological advancements and innovation in Continence Care product development, Hollister is also known for innovative customer service that focusses on personal connections that help improve the quality of people’s lives while adding value to healthcare. At Hollister, our overriding goal is to make a difference in each person’s life journey by bringing to market innovative products such as VaPro and Infyna catheter brands.
Takeda Pharmaceutical Company Limited is headquartered in Japan and is a global, values-based, R&D-driven biopharmaceutical leader committed to translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
Additional information about Takeda UK Ltd. is available through its corporate website, www.takeda.com/en-gb.